Research on high-throughput detection of plasma cell-free DNA for targeted therapy-related genes screening and prognosis prediction in non-small cell lung cancer patients

Background and purpose: High-throughput detection of plasma cell-free DNA (cfDNA) is widely used for multi-cancer targeted therapy drug screening, and this study investigated the relationship between the type and number of plasma cfDNA class Ⅰ and Ⅱ targeted therapy-related gene variants and cancer...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Qiling DENG, Di SONG, Kexin XI, Xiaoting XIE, Xiaoyan WU, Wei ZHAO
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Editorial Office of China Oncology 2025-04-01
Reeks:	Zhongguo aizheng zazhi
Onderwerpen:	Non-small cell lung cancer Plasma cell-free DNA High-throughput sequencing Gene mutation sites Targeted therapy drug selection Survival analysis
Online toegang:	http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2025.04.003
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!